NCT02542371View on ClinicalTrials.gov

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
HIV
Interventions
OTHER

Arterial Imaging

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Navidea Biopharmaceuticals

INDUSTRY

collaborator

Havard University Center for AIDS Research

UNKNOWN

lead

Massachusetts General Hospital

OTHER